12 completed, 4 recruiting, 3 unknown, 2 withdrawn. 21 Phase 2, 6 Phase 1, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 21 | Completed 12, Recruiting 4, Unknown 3, Withdrawn 2 |
| Phase 1 | 6 | Recruiting 3, Withdrawn 2, Completed 1 |
| Phase 3 | 3 | Completed 3 |
Follow Cilostazol: new trials by email Literature Review of Cilostazol trials Research Report on Cilostazol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease Standard therapy, Cilostazol - Fatty Liver | Phase 1 / Phase 2 | Recruiting | Tanta University | 50 | 2025-11-01 | 2025-11-25 |
| Cilostazol in Parkinson's Disease Cilostazol, Placebo, Standard treatment - Parkinson's Disease | Phase 2 | Unknown | Ain Shams University | 50 | 2024-10-01 | 2024-09-25 |
| Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers Best Practice, Cilostazol, Cryocompression Therapy - Cervical Carcinoma, Fallopian Tube Carcinoma | Phase 2 | Recruiting | Emory University | 70 | 2024-08-01 | 2026-08-27 |
| EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE) Low-dose Y-6 sublingual tablets, High-dose Y-6 sublingual tablets, Low-dose Cilostazol - Acute Ischemic Stroke, Large Vessel Occlusion | Phase 2 | Unknown | Beijing Tiantan Hospital | 300 | 2023-11-01 | 2023-11-18 |
| Impact of Cilostazol Versus Cilostazol and Selenium Combination on the Healing of Diabetic Foot Ulcer Patients Cilostazol, Selenium - Wound Heal | Phase 2 / Phase 3 | Completed | Ain Shams University | 206 | 2023-10-19 | 2025-02-18 |
| The Effect of Cilostazol on Rheumatoid Arthritis Patients Cilostazol 100 MG, conventional synthetic antirheumatic drugs - Rheumatoid Arthritis | Phase 2 / Phase 3 | Completed | Ain Shams University | 70 | 2022-11-01 | 2026-01-02 |
| Efficacy of Cilostazol in Prevention of Peripheral Neuropathy Cilostazol, Placebo - Peripheral Neuropathy, Breast Cancer | Phase 1 / Phase 2 | Completed | Mansoura University | 71 | 2022-03-28 | 2023-03-15 |
| Cilostazol for HFpEF Cilostazol 100Mg Tab, Placebo - Heart Failure With Preserved Ejection Fraction | Phase 2 | Completed | University of Minnesota | 25 | 2021-09-01 | 2023-12-15 |
| The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With Osteoarthritis Cilostazol 50 MG, Placebo - Osteoarthritis | Phase 1 / Phase 2 | Withdrawn | Sadat City University | 2021-03-01 | 2025-07-14 | |
| Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver Disease Cilostazol 50 MG, Placebo - Fatty Liver, Nonalcoholic | Phase 1 / Phase 2 | Withdrawn | Sadat City University | 2021-02-16 | 2025-07-14 | |
| Retina is a Marker for Cerebrovascular Heath Cilostazol - Cerebral Small Vessel Diseases, Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy | Phase 1 / Phase 2 | Recruiting | Mayo Clinic | 100 | 2021-02-09 | 2026-08-03 |
| Oxford Haemodynamic Adaptation to Reduce Pulsatility Trial Sildenafil, Cilostazol, Placebo - Small Vessel Cerebrovascular Disease | Phase 2 | Completed | University of Oxford | 75 | 2019-07-11 | 2025-11-19 |
| Antiplatelet Therapy in Chronic Urticaria Desloratadine plus cilostazol and dipyridamole, Desloratadine - Chronic Urticaria | Phase 2 | Unknown | Chulalongkorn University | 12 | 2018-06-01 | 2024-02-21 |
| LACunar Intervention (LACI-2) Trial-2 Isosorbide Mononitrate XL (ISMN), Cilostazol, ISMN XL and Cilostazol - Cerebral Small Vessel Diseases, Stroke, Lacunar | Phase 2 / Phase 3 | Completed | University of Edinburgh | 363 | 2018-01-08 | 2024-11-12 |
| Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS) Cilostazol, Leucovorin, Pirfenidone - Multiple Sclerosis | Phase 1 / Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 250 | 2017-08-11 | 2026-10-20 |
| Lacunar Intervention Trial 1 (LACI-1) isosorbide mononitrate, cilostazol - Cerebral Small Vessel Diseases, Cognitive Impairment | Phase 2 | Completed | University of Edinburgh | 57 | 2016-03-01 | 2018-01-19 |
| A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID) Cilostazol, Placebo - Mild Cognitive Impairment | Phase 2 | Completed | National Cerebral and Cardiovascular Center, Japan | 166 | 2015-05-01 | 2020-12-04 |
| Cilostazol and Its Effects on Resumption of Meiosis in the Human Ovary Cilostazol - Contraception | Phase 2 | Completed | University of Southern California | 4 | 2013-07-01 | 2015-05-12 |
| Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety Cilostazol, Probucol - Peripheral Artery Disease | Phase 2 | Completed | Korea Otsuka Pharmaceutical Co., Ltd. | 80 | 2010-05-19 | 2022-07-18 |
| Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication K-134, Cilostazol 100 mg BID, Placebo - Intermittent Claudication | Phase 2 | Completed | Kowa Research Institute, Inc. | 387 | 2008-11-01 | 2012-03-22 |
Showing 20 of 21. Sign in to see all of them.
Cerebral Small Vessel Diseases (4) · Cognitive Dysfunction (2) · Intermittent Claudication (2) · Peripheral Arterial Disease (2) · Alzheimer Disease (1) · Arthritis, Rheumatoid (1) · Breast Neoplasms (1) · CADASIL (1) · Chronic Urticaria (1) · Coronary Artery Disease (1) · Dementia (1) · Disease (1) · Fallopian Tube Neoplasms (1) · Fatty Liver (1) · Ischemic Stroke (1)
Ain Shams University (3) · Sadat City University (2) · University of Edinburgh (2) · Beijing Tiantan Hospital (1) · Chulalongkorn University (1) · Emory University (1) · Korea Otsuka Pharmaceutical Co., Ltd. (1) · Kowa Research Institute, Inc. (1) · Mansoura University (1) · Mayo Clinic (1) · National Cerebral and Cardiovascular Center, Japan (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Sanofi (1) · Tanta University (1) · University of Minnesota (1)
Egypt (7) · United States (7) · United Kingdom (3) · Russia (2) · Austria (1) · Canada (1) · France (1) · Japan (1) · Poland (1) · South Africa (1) · South Korea (1) · Thailand (1)
Bibiana Bielekova, M.D. (1) · Dr A Webb, DPhil (1) · Jettanong Klaewsongkram, MD (1) · Joanna M Wardlaw, MB ChB (1) · Joanna M Wardlaw, MD (1) · Michelle P Lin, MD, MPH (1) · Roger Morgan, M.D., FACS (1) · Susan C Modesitt (1) · Yilong Wang, PhD+MD (1)
PMID 21612611, PMID 34746425, PMID 34847709, PMID 35833913, PMID 37222252, PMID 38048134, PMID 38832504, PMID 39552153, PMID 39614707, PMID 40246318, PMID 40371642, PMID 41495844, PMID 42621146
2015 (1), 2016 (1), P30CA138292 (1)